A mitochondria-targeting magnetothermogenic nanozyme for magnet-induced synergistic cancer therapy.
Fenton reaction
Ir@MnFe(2)O(4) NPs
Magnetothermogenic nanozyme
Mitochondria-targeting
Synergistic therapy
Journal
Biomaterials
ISSN: 1878-5905
Titre abrégé: Biomaterials
Pays: Netherlands
ID NLM: 8100316
Informations de publication
Date de publication:
29 Apr 2020
29 Apr 2020
Historique:
received:
12
01
2020
revised:
27
04
2020
accepted:
27
04
2020
pubmed:
11
5
2020
medline:
11
5
2020
entrez:
11
5
2020
Statut:
aheadofprint
Résumé
Magnetic hyperthermia therapy (MHT) and chemodynamic therapy (CDT) are non-invasive in situ treatments without depth limitations and with minimum adverse effects on surrounding healthy tissue. We herein report a mitochondria-targeting magnetothermogenic nanozyme (Ir@MnFe
Identifiants
pubmed: 32387686
pii: S0142-9612(20)30325-2
doi: 10.1016/j.biomaterials.2020.120079
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
120079Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest There are no conflicts to declare.